These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The P2X4 purinergic receptor impacts liver regeneration after partial hepatectomy in mice through the regulation of biliary homeostasis. Besnard A; Gautherot J; Julien B; Tebbi A; Garcin I; Doignon I; Péan N; Gonzales E; Cassio D; Grosse B; Liu B; Safya H; Cauchois F; Humbert L; Rainteau D; Tordjmann T Hepatology; 2016 Sep; 64(3):941-53. PubMed ID: 27301647 [TBL] [Abstract][Full Text] [Related]
3. The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis. Hamoudi C; Zhao C; Abderrazak A; Salem M; Fortin PR; Sévigny J; Aoudjit F J Immunol; 2022 Mar; 208(5):1115-1127. PubMed ID: 35165166 [TBL] [Abstract][Full Text] [Related]
4. Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway. Li ZX; Sheng XD; Wang YL; Wen Lv X Int Immunopharmacol; 2022 Dec; 113(Pt A):109326. PubMed ID: 36252487 [TBL] [Abstract][Full Text] [Related]
12. P2X4: A fast and sensitive purinergic receptor. Suurväli J; Boudinot P; Kanellopoulos J; Rüütel Boudinot S Biomed J; 2017 Oct; 40(5):245-256. PubMed ID: 29179879 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats. Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637 [TBL] [Abstract][Full Text] [Related]
14. P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. Maynard JP; Lu J; Vidal I; Hicks J; Mummert L; Ali T; Kempski R; Carter AM; Sosa RY; Peiffer LB; Joshu CE; Lotan TL; De Marzo AM; Sfanos KS J Pathol; 2022 Feb; 256(2):149-163. PubMed ID: 34652816 [TBL] [Abstract][Full Text] [Related]
15. Macrophage autophagy protects against liver fibrosis in mice. Lodder J; Denaës T; Chobert MN; Wan J; El-Benna J; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F Autophagy; 2015; 11(8):1280-92. PubMed ID: 26061908 [TBL] [Abstract][Full Text] [Related]
16. [Purinergic receptors and hepatic fibrosis]. Chouiter A; Dali AR; Dellis O Med Sci (Paris); 2020 May; 36(5):525-528. PubMed ID: 32452377 [TBL] [Abstract][Full Text] [Related]
17. Dissection of P2X4 and P2X7 Receptor Current Components in BV-2 Microglia. Trang M; Schmalzing G; Müller CE; Markwardt F Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187309 [TBL] [Abstract][Full Text] [Related]
18. Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases. Bansal R; Nakagawa S; Yazdani S; van Baarlen J; Venkatesh A; Koh AP; Song WM; Goossens N; Watanabe H; Beasley MB; Powell CA; Storm G; Kaminski N; van Goor H; Friedman SL; Hoshida Y; Prakash J Exp Mol Med; 2017 Nov; 49(11):e396. PubMed ID: 29147013 [TBL] [Abstract][Full Text] [Related]
19. Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression. Yoshida K; Ito M; Hoshino Y; Matsuoka I Biochem Biophys Res Commun; 2017 Dec; 493(4):1587-1593. PubMed ID: 28988113 [TBL] [Abstract][Full Text] [Related]
20. Podocyte Purinergic P2X4 Channels Are Mechanotransducers That Mediate Cytoskeletal Disorganization. Forst AL; Olteanu VS; Mollet G; Wlodkowski T; Schaefer F; Dietrich A; Reiser J; Gudermann T; Mederos y Schnitzler M; Storch U J Am Soc Nephrol; 2016 Mar; 27(3):848-62. PubMed ID: 26160898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]